For a 65‑year‑old male with type 1 diabetes on neutral protamine Hagedorn insulin (NPH) 22 units at 8 pm, insulin sensitivity factor (ISF) 25 mg/dL per unit, receiving continuous intravenous fluid (IV fluid) at 50 mL/h (increased to 60 mL/h at 4 am) with blood glucose rising from ~273 mg/dL at 8 pm to 353 mg/dL at 7 am, what should his morning NPH dose be and should his ISF be adjusted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

NPH Dose and ISF Adjustment for Type 1 Diabetes with Persistent Hyperglycemia on Tube Feeding

Increase the evening NPH dose by 10-15% (from 22 units to 24-25 units at 8 pm) and add a morning NPH dose of approximately 12-14 units (2/3 of total daily NPH) to address the progressive overnight hyperglycemia; the ISF of 25 mg/dL per unit should remain unchanged for correction doses.

Rationale for NPH Dose Adjustment

This patient demonstrates clear inadequacy of the current single evening NPH regimen, with blood glucose rising progressively from 273 mg/dL at 8 pm to 353 mg/dL at 7 am—an 80 mg/dL increase overnight despite NPH administration. The 2025 ADA Standards of Care 1 provide explicit guidance for this scenario:

Converting to Twice-Daily NPH

When bedtime NPH fails to control fasting glucose, convert to a twice-daily NPH regimen:

  • Calculate total NPH dose as 80% of current bedtime dose: 22 × 0.8 = 17.6 units total daily NPH
  • Distribute as 2/3 morning (approximately 12 units) and 1/3 evening (approximately 6 units)
  • However, given the marked hyperglycemia (blood glucose >300 mg/dL), the guidelines 1 recommend considering this a scenario requiring intensification rather than simple redistribution

Alternative Intensification Approach

Given the persistent hyperglycemia, a more aggressive approach is warranted:

  • Increase the evening NPH by 10-15% (standard titration increment per guidelines 1): 22 × 1.10 to 1.15 = 24-25 units
  • Add morning NPH at approximately 12-14 units to provide daytime basal coverage
  • This totals approximately 36-39 units daily NPH, representing appropriate intensification for blood glucose levels consistently >300 mg/dL

Impact of Continuous Tube Feeding

The continuous tube feeding at 60 mL/hr creates a persistent nutritional load requiring continuous insulin coverage. The 2018 and 2021 ADA hospital care guidelines 2, 3 and the 2022 Endocrine Society guideline 4 address enteral nutrition:

  • For continuous tube feeding: Continue basal insulin (NPH or long-acting analog) and add nutritional insulin coverage
  • NPH is appropriate for continuous feeding as it provides intermediate-acting coverage 2, 5
  • The increase in tube feeding rate from 50 to 60 mL/hr at 4 am likely contributed to the accelerated glucose rise from 337 to 353 mg/dL

Specific Dosing for Tube Feeding Context

The 2018 guideline 2 recommends for continuous enteral feeding:

  • Continue or establish basal insulin (5 units NPH every 12 hours or 10 units glargine daily as starting point if no prior basal)
  • Add regular insulin every 6 hours or rapid-acting every 4 hours: 1 unit per 10-15 g carbohydrate
  • This patient already has basal NPH but needs intensification given persistent hyperglycemia

ISF (Insulin Sensitivity Factor) Assessment

The ISF of 25 mg/dL per unit should remain unchanged for the following reasons:

Evidence Supporting Current ISF

  • The ISF of 1:25 (meaning 1 unit lowers glucose by 25 mg/dL) is within reasonable range for adults with type 1 diabetes
  • The 1800 rule (1800 ÷ total daily dose) is commonly used: if total daily insulin is approximately 40-50 units, the calculated ISF would be 36-45 mg/dL per unit, suggesting the current ISF of 25 is actually somewhat conservative
  • Recent pediatric data 6, 7 demonstrates significant diurnal variation in ISF, with morning requiring more insulin (lower ISF values), which may apply to adults as well

Why Not Change ISF Now

  • The primary problem is inadequate basal insulin coverage, not incorrect correction factor
  • The progressive rise in glucose overnight (273→288→337→353) indicates insufficient basal insulin, not that corrections are ineffective
  • Changing ISF without first optimizing basal insulin would mask the underlying basal insufficiency
  • The 2025 ADA guidelines 1 emphasize titrating basal insulin first before adjusting other parameters

Dawn Phenomenon Consideration

The accelerated glucose rise from 4 am (337 mg/dL) to 7 am (353 mg/dL) suggests dawn phenomenon, well-documented with NPH insulin 8, 9:

  • NPH given at 8 pm has peak action at approximately 4-6 hours (midnight to 2 am), with waning effect by early morning
  • Research demonstrates 8 that splitting NPH (regular insulin at dinner, NPH at bedtime) reduces nocturnal hypoglycemia and improves fasting glucose
  • The 2002 study 8 showed split regimen reduced nocturnal hypoglycemia from 0.28 to 0.10 episodes/patient-day and lowered fasting glucose from 160 to 137 mg/dL
  • However, for this patient, the issue is hyperglycemia, not hypoglycemia, requiring dose increase rather than timing change alone

Practical Implementation

Morning Dose (This Morning at 7 am)

Give 12-14 units NPH subcutaneously now to establish twice-daily coverage:

  • This represents approximately 2/3 of the redistributed total daily NPH dose
  • Will provide basal coverage through the day while tube feeding continues at 60 mL/hr
  • Monitor blood glucose every 4-6 hours initially 2, 3

Evening Dose (Tonight at 8 pm)

Give 24-25 units NPH (increased from 22 units):

  • This represents the 1/3 evening portion plus intensification for persistent hyperglycemia
  • Alternatively, could give 6 units as strict redistribution, but given blood glucose >300 mg/dL, intensification is appropriate per guidelines 1

Correction Doses

Continue using ISF of 1:25 for correction insulin:

  • At 7 am with glucose 353 mg/dL, if target is 150 mg/dL: (353-150)/25 = 8 units rapid-acting insulin correction
  • Administer corrections with rapid-acting insulin (regular every 6 hours or rapid-acting analog every 4 hours) 2, 5
  • For continuous tube feeding, the 2018 guideline 2 recommends regular insulin every 6 hours or rapid-acting every 4 hours for hyperglycemia

Monitoring and Titration

Short-Term (24-48 Hours)

  • Monitor blood glucose every 4-6 hours minimum 2, 3
  • Assess for hypoglycemia, particularly overnight (if glucose drops >20%, reduce corresponding NPH dose by 10-20%) 1
  • If tube feeding is interrupted, start 10% dextrose infusion at 50 mL/hr immediately to prevent hypoglycemia 2, 5, 10

Medium-Term Adjustment (3-7 Days)

  • If fasting glucose remains >180 mg/dL, increase evening NPH by additional 2 units every 3 days 1
  • If daytime glucose (pre-dinner) remains elevated, increase morning NPH by 2 units every 3 days
  • The 2025 ADA guideline 1 recommends evidence-based titration: increase 2 units every 3 days to reach fasting plasma glucose goal without hypoglycemia

Long-Term Considerations

Consider transition to basal-bolus regimen or basal analog:

  • The 2025 ADA guidelines 1 note that switching from evening NPH to a basal analog should be considered if hypoglycemia develops or for better glycemic control
  • For type 1 diabetes with blood glucose consistently >300 mg/dL, full basal-bolus regimen may ultimately be needed 1
  • Studies demonstrate 11, 12 that long-acting analogs (glargine, degludec) provide more stable basal coverage than NPH with less hypoglycemia

Critical Safety Points

Hypoglycemia Risk

  • If tube feeding is stopped or interrupted: Immediately start 10% dextrose at 50 mL/hr 2, 5, 10
  • NPH has peak action 4-6 hours after administration; monitor glucose closely during these periods
  • Have glucagon available for emergency hypoglycemia 1

Glucocorticoid Consideration

  • If patient is on glucocorticoids (not mentioned but common in hospitalized patients), NPH timing is actually advantageous 3, 5, 10
  • Morning NPH dosing is specifically recommended for steroid-induced hyperglycemia 1
  • The 2021 guideline 3 recommends NPH given concomitantly with steroids as it peaks 4-6 hours after administration, matching steroid-induced hyperglycemia pattern

Type 1 Diabetes Specific Concerns

  • This patient has type 1 diabetes and requires continuous insulin coverage—never discontinue basal insulin entirely
  • The progressive hyperglycemia despite NPH indicates absolute insulin deficiency requiring intensification
  • Risk of diabetic ketoacidosis if insulin is inadequate, particularly with illness or stress

Summary Algorithm

  1. Immediate (this morning): Give 12-14 units NPH + correction dose of ~8 units rapid-acting insulin
  2. Tonight (8 pm): Give 24-25 units NPH (increased from 22)
  3. Ongoing corrections: Use ISF 1:25 with rapid-acting insulin every 4-6 hours as needed
  4. Monitor: Blood glucose every 4-6 hours minimum
  5. Titrate: Increase NPH by 2 units every 3 days if fasting glucose >180 mg/dL
  6. Safety: If tube feeding stops, start 10% dextrose immediately

This approach addresses the inadequate basal insulin coverage while maintaining appropriate correction dosing, following evidence-based guidelines for type 1 diabetes management in the hospital setting with enteral nutrition 1, 2, 3, 5.

References

9
Research

Nocturnal blood glucose and IGFBP-1 changes in type 1 diabetes: Differences in the dawn phenomenon between insulin regimens.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2010

10
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

For a 78‑kg adult with type 1 diabetes on dexamethasone 2 mg, currently using insulin glargine (Lantus) 20 U, NPH (neutral protamine Hagedorn) insulin 100 U at 6 pm, insulin‑to‑carbohydrate ratio 1 U per 10 g carbohydrate, daytime insulin sensitivity factor 50 mg/dL per unit, and nighttime insulin sensitivity factor 15 mg/dL per unit, and given the reported glucose readings, what should the insulin‑to‑carbohydrate ratio, glargine dose, and NPH dose be adjusted to?
What should the Insulin Sensitivity Factor (ISF) rate be if the current 1:10 ratio requires an additional 12 units of insulin?
What should be the dose of insulin glargine (Lantus), insulin sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) for a 45‑year‑old man weighing 98.4 kg with newly diagnosed type 2 diabetes, hemoglobin A1c 14.5%, normal renal function, not in diabetic ketoacidosis, who received insulin drip rates of 2, 2, 3, 2, 2, 3, 3, 3, and 2 units over the past 8 hours?
What should the morning (8 am) NPH insulin dose, the evening (8 pm) NPH insulin dose, the insulin‑to‑carbohydrate ratio, and the insulin sensitivity factor be for a 56‑year‑old female with type 2 diabetes, weight 81 kg, receiving dexamethasone 12 mg at 20:00 and methylprednisolone 81.25 mg at 20:00, currently on 8 U NPH at 08:00 with an insulin sensitivity factor of 50 mg/dL per unit and an insulin‑to‑carbohydrate ratio of 20 g per unit?
For a 47-year-old male weighing 120 kg who is being changed from dexamethasone 10 mg every 6 hours to 10 mg every 12 hours, what should the 10 am Neutral Protamine Hagedorn (NPH) dose be, what should the 8 pm NPH dose be, and what should the insulin sensitivity factor (ISF) and insulin-to-carbohydrate ratio (ICR) be?
What is an equivalent of Tussionex (hydrocodone + chlorpheniramine) when insurance will not cover it?
What is the proper dosing and administration of S‑8020 vaginal cream containing 1 mg estradiol and 20 mg micronized progesterone?
What should I do if I wake up at night with chills, trembling, and a rapid heart rate of about 128 beats per minute that lasts for several hours and then resolves?
How does squamous cell carcinoma of the vulva typically present in women over 60?
What is the normal left atrial diameter in men and women?
Is the compounded Bi‑Est 80:20 vaginal cream containing 0.5 mg estriol/estradiol and 10 mg micronized progesterone applied daily appropriate for a post‑menopausal woman with a uterus, and what evidence‑based regimen should be used instead?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.